Skip to main content
A Tiered TPA Product · LFP-15.04

Black: The Full-Stack TPA and What It Offers That Nobody Else Does

By Syam Adusumilli · 11 min read
In a Hurry? Read the executive summary.

LFP-15.04
#

Black is the flagship. It includes everything in Plus, and adds geographic arbitrage at scale, SDOH signal integration, advanced chronic disease interception, mental health access innovation, social isolation screening, GLP-1 management, full member concierge, predictive analytics, and a broker intelligence portal. For a mobile workforce that can receive care anywhere, Black transforms geographic flexibility into a cost advantage that no geographically anchored plan can match. The product is structurally unavailable from any competitor that has not built the same operational infrastructure.

The argument for Black is not that it serves every employer in the 1-to-50 market. It does not. The argument is that it serves a specific population, high-income professional services firms and remote-first technology companies with mobile workforces, better than any alternative in the market. For that population, Black produces outcomes and economics that justify the premium pricing. For every other employer, Core or Plus is the right tier.

Geographic Arbitrage at Scale
#

Cross-border medical care coordination represents the core differentiator of Black. For planned surgical procedures, members can access JCI-accredited facilities in Mexico, Canada, the Bahamas, and other international destinations at 40% to 70% savings compared to US facility pricing (Medical Tourism Packages). Mexico alone has over 100 JCI-accredited hospitals and clinics, and medical tourism analysis indicates that dental and bariatric procedures offer approximately 75% savings while orthopedic treatments provide approximately 70% savings compared to US costs (Market.us). Thailand has over 100 JCI-accredited facilities and procedures cost 30% to 70% less than in Western countries (Market.us). The savings are structural, driven by lower labor costs, different regulatory overhead, and competitive international pricing.

The operational infrastructure for geographic arbitrage does not exist at any current TPA serving the small group market. Building it requires international facility relationships, quality monitoring protocols, travel logistics partnerships, complication management procedures, a legal framework for international care coordination, and member communication and support systems. This infrastructure takes years to develop. It cannot be purchased from a vendor or replicated in a single product cycle.

The Black cross-border medical care program includes facility vetting against JCI accreditation and ongoing quality monitoring, travel and lodging coordination for the member and a companion, pre-procedure preparation including consultations with both the international provider and the member’s US-based primary care physician, post-procedure recovery support at the destination, complication protocols including medical evacuation arrangements, and coordination with the member’s US-based provider network for follow-up care upon return. The member does not manage this complexity. The concierge manages it on the member’s behalf.

Cross-border dental extends the geographic arbitrage model to dental procedures. Crowns, implants, and restorative work in JCI-accredited dental facilities in border markets deliver 50% to 80% savings over US pricing (Medical Tourism Packages). For the Black population, high-income professionals comfortable with travel, cross-border dental is a significant value-add that captures savings outside the medical spend that most cost management programs address. A single dental implant procedure that costs $4,000 in the US may cost $800 to $1,500 in Mexico. For an employer with 30 employees, the aggregate dental savings across the population can be substantial.

International pharmacy purchasing offers savings of 50% to 90% on specific high-cost medications compared to US retail pricing (KFF). The Utah Public Employees Health Program has operated a pharmacy tourism program since 2020, sending members to Canada and Mexico to fill prescriptions for high-cost specialty drugs, saving approximately $250,000 in its first year (WBUR). The program targets specialty drugs for conditions such as rheumatoid arthritis and multiple sclerosis where the variance between US and international pricing justifies the logistics. Black integrates international pharmacy purchasing into the concierge service. When a member is prescribed a high-cost medication, the concierge evaluates international alternatives, manages the logistics if appropriate, and ensures the member receives the same medication at a fraction of the cost.

Domestic facility steering at Black expands the Plus capability to include a broader network of cost-effective facilities, centers of excellence for specific procedures, and bundled payment arrangements that include travel. Where Plus routes members to lower-cost domestic alternatives, Black adds the international options and coordinates the decision process through the concierge. The member receives a side-by-side comparison: in-network facility at standard cost, lower-cost domestic alternative with travel, and international option with full coordination. The member chooses. The concierge executes.

The Full Capability Stack Beyond Plus
#

SDOH signal integration moves beyond standard claims analysis to incorporate social determinants of health into member identification and intervention routing. Claims data signals that indicate housing instability, transportation barriers, food insecurity, or social isolation are cross-referenced with external data sources and routed to community resources. A member with repeated emergency department visits for conditions that could be managed in primary care may be experiencing transportation barriers. A member with declining medication adherence may be experiencing financial stress. Black identifies these signals and routes the member to available resources through the concierge rather than allowing the underlying social determinant to drive preventable utilization.

Advanced chronic disease interception goes beyond the Plus chronic disease programs by adding predictive identification. Rather than waiting for a member to be diagnosed with diabetes or heart failure, Black uses claims data patterns, pharmacy data, and biometric data where available to identify members moving toward high-cost chronic disease events. A member with pre-diabetic indicators, rising BMI trend, and pharmacy claims suggesting inadequate condition management receives proactive outreach before the diagnosis occurs. The goal is interception, not just management. The economics of chronic disease management shift dramatically when intervention occurs before the condition becomes established.

Mental health access innovation addresses behavioral health through expanded telehealth access, reduced barriers including no prior authorization and lower copays, and integration with primary care. Social isolation screening specifically addresses the remote and fractional workforce that Black targets. Remote workers are uniquely vulnerable to isolation-driven mental health decline. Standard employer health programs do not screen for social isolation because they assume the workplace provides baseline social connection. For the distributed workforce, that assumption fails. Black screens for isolation and routes members to appropriate intervention including virtual community, coaching, and clinical resources.

GLP-1 management addresses the fastest-growing pharmacy cost driver in employer health benefits. According to KFF research, 34% of people with employer-sponsored health insurance, approximately 36.2 million individuals, have a body mass index that would medically qualify them for a GLP-1 medication (KFF 2025). GLP-1 cost per member per month increased from $4.34 in 2022 to $27.23 in Q1 2025 (WTW). Among employers with over 5,000 workers, 43% now cover GLP-1 medications for weight loss, up from 28% in 2024 (KFF 2025). The drugs work, but the cost impact is substantial and many employers are reconsidering coverage.

Black includes a structured GLP-1 management program that combines clinical monitoring, dose optimization, lifestyle integration, and cost management through international pharmacy purchasing where appropriate. The program does not simply cover GLP-1 prescriptions. It manages them as part of a comprehensive metabolic health pathway that includes coaching, nutrition support, and accountability. Members who discontinue GLP-1 treatment, a significant adherence challenge, receive proactive outreach. Members who achieve target weight loss receive transition support to maintain results. The goal is clinical outcomes, not just drug coverage.

Full member concierge represents the human interface for the entire Black capability stack. Every Black member has access to a dedicated care coordination resource, not a phone tree but a named individual or small team who manages the member’s interaction with the entire health system. The concierge handles provider selection, procedure coordination, pharmacy optimization, cross-border care logistics, claims questions, and benefits guidance. When a Black member has a health need, they contact their concierge. The concierge identifies the options, presents them with cost and quality comparisons, and coordinates the chosen path.

The concierge model creates the accountability that makes geographic arbitrage possible. A member considering a surgical procedure in Mexico needs confidence that the facility is legitimate, the logistics are managed, and complications will be handled. The concierge provides that confidence through direct coordination. A member considering international pharmacy purchasing needs assurance that the medication is authentic and the supply chain is secure. The concierge provides that assurance through vetted relationships and chain of custody documentation.

Predictive analytics enable the concierge model to be proactive rather than reactive. When the analytics identify a member approaching a high-cost event, the concierge reaches out before the event occurs. The outreach might be a conversation about managing a chronic condition, a referral to an MSK pathway before surgery is scheduled, or an inquiry about a pharmacy claim that suggests inadequate disease management. The analytics convert the concierge from a reactive service function into a proactive care coordination capability.

The broker intelligence portal provides the distribution layer with the analytical infrastructure that transforms advisor relationships. The portal delivers plan-level analytics designed for broker use: claims experience by category, program engagement rates, savings attribution, renewal projections, and benchmarking against comparable employers. The broker whose clients are on Black has visibility into the value being delivered. The renewal conversation is not a negotiation about price. It is a review of demonstrated performance.

Target Segment
#

Black serves a narrow but well-defined employer population. Professional services firms with partners and executives who expect premium benefits and mobile workforces represent the primary segment. These employers, law firms, consulting practices, accounting firms, financial advisory firms, have partners who have experienced premium benefits at prior employers and will not accept commodity coverage. The retention argument for benefits quality is strongest in this segment. The workforce is mobile enough to access international care when the savings are significant.

Remote-first technology companies represent the second segment. These employers have workforces distributed across multiple states, sometimes multiple countries. The workforce is high-income, health-literate, and accustomed to digital services. The geographic arbitrage proposition resonates with employees who are already mobile. The SDOH screening and social isolation features address a real risk for distributed workforces with limited social infrastructure outside the workplace.

High-income small employers in other industries represent the third segment. The owner of a 15-person dental practice with high-income employees. The principal of a 20-person architecture firm. The proprietor of a specialty manufacturing operation where skilled employees are irreplaceable. These employers compete for talent with larger organizations and use benefits quality as a differentiation tool. Black gives them a benefits package that competes with enterprise offerings.

The Operational Infrastructure
#

The capabilities that define Black require operational infrastructure that does not exist at any current TPA serving the small group market. The cross-border care network requires facility relationships, credentialing agreements, quality monitoring protocols, and complication management procedures. The international pharmacy relationships require chain of custody documentation, authenticity verification, and regulatory compliance. The concierge model requires staffing, training, and systems to support personalized member relationships at scale. The predictive analytics platform requires data architecture, model development, and integration with member outreach workflows.

Building this infrastructure takes years. Facility relationships require negotiation, site visits, and performance monitoring. Quality protocols require development, testing, and continuous improvement. The concierge model requires hiring, training, and culture development. The analytics platform requires data integration, model validation, and operational embedding. None of this can be purchased off the shelf or replicated quickly. The timeline from decision to operational capability spans 18 to 36 months for each major component, and the components must work together.

The infrastructure investment creates the competitive moat that LFP-15.12 examines in detail. A competitor that decides to offer geographic arbitrage next year faces years of development before they can match the Black capability stack. By the time they build the infrastructure, the TPA that built Black first has accumulated years of operational experience, facility relationships, and member outcome data that informs continuous improvement. The moat is not a patent or a regulatory barrier. It is the accumulated operational capability that cannot be replicated without the same investment timeline.

Pricing and Economics
#

Black pricing reflects the capability stack and the target population. The administrative premium over Plus is substantial because the concierge model, the international coordination infrastructure, and the advanced analytics require investment that Plus does not carry. However, the economic proposition for the Black employer is self-funding through savings capture.

Consider a 30-person professional services firm with four planned surgical procedures per year, two members on specialty pharmacy regimens, and standard chronic disease prevalence. At Plus, the firm receives domestic cost management that produces measurable savings. At Black, the firm adds international procedure options that can save 40% to 70% per steered procedure, international pharmacy purchasing that can save 50% to 90% on specialty medications, and concierge coordination that ensures members actually use the programs.

If one surgical procedure shifts from a US facility at $50,000 to a Mexican JCI-accredited facility at $25,000, the savings from that single procedure exceed the annual Black premium differential for the entire group. If two members on specialty medications shift to international pharmacy purchasing at 60% savings, the pharmacy savings alone can justify Black pricing. The economics work for the employer who has the cost profile and the population characteristics that Black addresses.

The pricing architecture does not publish specific dollar figures because the market will determine pricing through competitive dynamics. The principle is that Black is priced to be self-funding for the target population: employers with the procedure volume, specialty pharmacy exposure, and engagement capacity to capture the savings that Black enables.

How this article connects to others in Blue Gray Matters.

The cross-border care arbitrage analysis from LFP-10.04 provides the operational model for Black's international facility coordination at JCI-accredited facilities producing 40% to 70% surgical savings.
The international pharmacy purchasing model from LFP-10.05, including the Utah Public Employees Health Program precedent, informs Black's 50% to 90% medication savings through cross-border pharmacy logistics.
The geographic arbitrage framework from LFP-10.02 establishes the cost differential analysis that positions Black's cross-border care as a structural savings mechanism rather than a one-time discount.
The GLP-1 cost trajectory from LFP-09.03, with PMPM increasing from $4.34 in 2022 to $27.23 in Q1 2025, establishes the cost driver that Black's GLP-1 management program addresses through clinical monitoring and international purchasing.
The SDOH intervention framework from LFP-10.09 informs Black's social isolation screening and community resource routing for the remote workforce population.
The high-income professional services employer profile from LFP-04.05 defines the primary Black target segment: firms with mobile workforces, high willingness to pay, and sophisticated benefits expectations.
The fractional and portfolio worker population from LFP-06.03 describes the distributed, mobile workforce that makes Black's geographic arbitrage and social isolation screening operationally relevant.
The chronic disease interception and GLP-1 management strategies from LFP-10.10 are implemented in Black as predictive identification and proactive outreach before high-cost events occur.

Sources cited in this article.

  1. Kaiser Family Foundation. "2025 Employer Health Benefits Survey." KFF, 9 Oct. 2025, www.kff.org/health-costs/report/2025-employer-health-benefits-survey/.
  2. Kaiser Family Foundation. "FAQs on Prescription Drug Importation." KFF, 9 Aug. 2025, www.kff.org/health-costs/faqs-on-prescription-drug-importation/.
  3. "Medical Tourism Statistics and Facts (2026)." Market.us, 2 Feb. 2026, media.market.us/medical-tourism-statistics/.
  4. "Medical Tourism vs US Healthcare Cost Comparison." Medical Tourism Packages, 9 Jan. 2026, www.medicaltourismpackages.com/medical-tourism-vs-us-healthcare-cost-comparison/.
  5. "Perspectives from Employers on the Costs and Issues Associated with Covering GLP-1 Agonists for Weight Loss." Peterson-KFF Health System Tracker, 12 Jan. 2026, www.healthsystemtracker.org/brief/perspectives-from-employers-on-the-costs-and-issues-associated-with-covering-glp-1-agonists-for-weight-loss/.
  6. "Utah Funds Public Employees Traveling To Mexico, Canada To Save Money On Costly Prescription Drugs." WBUR Here and Now, 14 Feb. 2020, www.wbur.org/hereandnow/2020/02/14/utah-prescription-drugs-mexico.
  7. WTW. "GLP-1 Drugs in 2025: Cost, Access and Future of Obesity Treatment." WTW, 11 Apr. 2025, www.wtwco.com/en-us/insights/2025/04/glp-1-drugs-in-2025-cost-access-and-the-future-of-obesity-treatment.